[Therapeutic effect of d-penicillamine in scleroderma]. 1973

B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
June 1976, Ceskoslovenska pediatrie,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
January 1972, Scandinavian journal of rheumatology,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
February 1973, Lancet (London, England),
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
January 1982, Klinicheskaia meditsina,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
August 1976, British heart journal,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
May 1990, Archives of dermatology,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
January 1977, Scandinavian journal of rheumatology,
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
February 1974, Lancet (London, England),
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
August 1969, Munchener medizinische Wochenschrift (1950),
B Bogdanikowa, and J Rudy, and K Bernacka, and Z Palka
December 1999, La Revue de medecine interne,
Copied contents to your clipboard!